Heterogeneous Expression of Interleukin-18 and Its Receptor in B-Cell Lymphoproliferative Disorders Deriving from Naive, Germinal Center, and Memory B Lymphocytes

Clinical Cancer Research

Volumn 10, Issue 1 I, 2004, Pages 144-154

  Airoldi, Irma ^a   Raffaghello, Lizzia ^a   Cocco, Claudia ^a   Guglielmino, Roberta ^a   Roncella, Silvio ^b   Fedeli, Franco ^b   Gambini, Claudio ^a   Pistoia, Vito ^a  

^a G GASLINI INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 18 RECEPTOR BETA; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; LYMPHOPROLIFERATIVE DISEASE; MALE; MEMORY CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TONSIL; TUMOR ESCAPE;

APOPTOSIS; B-LYMPHOCYTES; FLOW CYTOMETRY; GERMINAL CENTER; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOLOGIC MEMORY; INTERLEUKIN-18; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; LEUKEMIA, B-CELL; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA; PROTEIN ISOFORMS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-18; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 1642453744     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-1026-3     Document Type: Article

References (49)

1. Nakanishi, K., Yoshimoto, T., Tsutsui, H., and Okamura, H. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol., 19: 423-474, 2001.
2. Fantuzzi, G., Puren, A. J., Harding, M. W., Livingston, D. J., and Dinarello, C. A. Interleukin-18 regulation of interferon γ production and cell proliferation as shown in interleukin-1β-converting enzyme (caspase-1)-deficient mice. Blood, 91: 2118-2125, 1998.
3. Kim, Y. M., Talanian, R. V., Li, J., and Billiar, T. R. Nitric oxide prevents IL-1β and IFN-γ-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1β-converting enzyme). J. Immunol., 161: 4122-4128, 1998.
4. Fantuzzi, G., and Dinarello, C. A. Interleukin-18 and interleukin-1β: two cytokine substrates for ICE (caspase-1). J. Clin. Immunol., 19: 1-11, 1999.
5. Kohno, K., Kataoka, J., Ohtsuki, T., Suemoto, Y., Okamoto, I., Usui, M., Ikeda, M., and Kurimoto, M. IFN-γ-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J. Immunol., 158: 1541-1550, 1997.
6. Robinson, D., Shibuya, K., Mui, A., Zonin, F., Murphy, E., Sana, T., Hartley, S. B., Menon, S., Kastelein, R., Bazan, F., and O'Garra, A. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFγB. Immunity, 7: 571-581, 1997.
7. Yoshimoto, T., Takeda, K., Tanaka, T., Ohkusu, K., Kashiwamura, S., Okamura, H., Akira, S., and Nakanishi, K. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-γ production. J. Immunol., 161: 3400-3407, 1998.
8. Dao, T., Ohashi, K., Kayano, T., Kurimoto, M., and Okamura, H. Interferon-γ-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell. Immunol., 173: 230-235, 1996.
9. Walker, W., Aste-Amezaga, M., Kastelein, R. A., Trinchieri, G., and Hunter, C. A. IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-γ. J. Immunol., 162: 5894-5901, 1999.
10. Hoshino, T., Wiltrout, R. H., and Young, H. A. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J. Immunol., 162: 5070-5077, 1999.
11. Takeda, K., Tsutsui, H., Yoshimoto, T., Adachi, O., Yoshida, N., Kishimoto, T., Okamura, H., Nakanishi, K., and Akira, S. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity, 8: 383-390, 1998.
12. Micallef, M. J., Ohtsuki, T., Kohno, K., Tanabe, F., Ushio, S., Namba, M., Tanimoto, T., Torigoe, K., Fujii, M., Ikeda, M., Fukuda, S., and Kurimoto, M. Interferon-γ-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-γ production. Eur. J. Immunol., 26: 1647-1651, 1996.
13. Leite-De-Moraes, M. C., Hameg, A., Pacilio, M., Koezuka, Y., Taniguchi, M., Van Kaer, L., Schneider, E., Dy, M., and Herbelin, A. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. J. Immunol., 166: 945-951, 2001.
14. Heuer, J. G., Tucker-McClung, C., and Hock, R. A. Neuroblastoma cells expressing mature IL-18, but not pro-IL-18, induce a strong and immediate antitumor immune response. J. Immunother., 22: 324-335, 1999.
15. Hara, I., Nagai, H., Miyake, H., Yamanaka, K., Hara, S., Micallef, M. J., Kurimoto, M., Gohji, K., Arakawa, S., Ichihashi, M., and Kamidono, S. Effectiveness of cancer vaccine therapy using cells transduced with the interleukin-12 gene combined with systemic interleukin-18 administration. Cancer Gene Ther., 7: 83-90, 2000.
16. Arai, N., Akamatsu, S., Arai, S., Toshimori, Y., Hanaya, T., Tanimoto, T., Ikeda, M., Tomura, M., Fujiwara, H., and Kurimoto, M. Interleukin-18 in combination with IL-2 enhances natural killer cell activity without inducing large amounts of IFN-γ in vivo. J. Interferon Cytokine Res., 20: 217-224, 2000.
17. Ju, D. W., Yang, Y., Tao, Q., Song, W. G., He, L., Chen, G., Gu, S., Ting, C. C., and Cao, X. Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity. Gene Ther., 7: 1672-1679, 2000.
18. Nagai, H., Hara, I., Horikawa, T., Fujii, M., Kurimoto, M., Kamidono, S., and Ichihashi, M. Antitumor effects on mouse melanoma elicited by local secretion of interleukin-12 and their enhancement by treatment with interleukin-18. Cancer Investig., 18: 206-213, 2000.
19. Akamatsu, S., Arai, N., Hanaya, T., Arai, S., Tanimoto, T., Fujii, M., Kohno, K., Micallef, M. J., Ikeda, M., and Kurimoto, M. Antitumor activity of interleukin-18 against the murine T-cell leukemia/lymphoma EL-4 in syngeneic mice. J. Immunother., 25 (Suppl. 1): S28-S34, 2002.
20. Kishida, T., Asada, H., Satoh, E., Tanaka, S., Shinya, M., Hirai, H., Iwai, M., Tahara, H., Imanishi, J., and Mazda, O. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice. Gene Ther., 8: 1234-1240, 2001.
21. Coughlin, C. M., Salhany, K. E., Wysocka, M., Aruga, E., Kurzawa, H., Chang, A. E., Hunter, C. A., Fox, J. C., Trinchieri, G., and Lee, W. M. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J. Clin. Investig., 101: 1441-1452, 1998.
22. Torigoe, K., Ushio, S., Okura, T., Kobayashi, S., Taniai, M., Kunikata, T., Murakami, T., Sanou, O., Kojima, H., Fujii, M., Ohta, T., Ikeda, M., Ikegami, H., and Kurimoto, M. Purification and characterization of the human interleukin-18 receptor. J. Biol. Chem., 272: 25737-25742, 1997.
23. Born, T. L., Thomassen, E., Bird, T. A., and Sims, J. E. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J. Biol. Chem., 273: 29445-29450, 1998.
24. Kunikata, T., Torigoe, K., Ushio, S., Okura, T., Ushio, C., Yamauchi, H., Ikeda, M., Ikegami, H., and Kurimoto, M. Constitutive and induced IL-18 receptor expression by various peripheral blood cell subsets as determined by anti-hlL-18R monoclonal antibody. Cell. Immunol., 189: 135-143, 1998.
25. Pages, F., Berger, A., Henglein, B., Piqueras, B., Danel, C., Zinzindohoue, F., Thiounn, N., Cugnenc, P. H., and Fridman, W. H. Modulation of interleukin-18 expression in human colon carcinoma: consequences for tumor immune surveillance. Int. J. Cancer, 84: 326-330, 1999.
26. Wang, Z. Y., Gaggero, A., Rubartelli, A., Rosso, O., Miotti, S., Mezzanzanica, D., Canevari, S., and Ferrini, S. Expression of interleukin-18 in human ovarian carcinoma and normal ovarian epithelium: evidence for defective processing in tumor cells. Int. J. Cancer, 98: 873-878, 2002.
27. Ek, S., Hogerkorp, C. M., Dictor, M., Ehinger, M., and Borrebaeck, C. A. Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells. Cancer Res., 62: 4398-4405, 2002.
28. Park, H., Byun, D., Kim, T. S., Kim, Y. I., Kang, J. S., Hahm, E. S., Kim, S. H., Lee, W. J., Song, H. K., Yoon, D. Y., Kang, C. J., Lee, C., Houh, D., Kim, H., Cho, B., Kim, Y., Yang, Y. H., Min, K. H., and Cho, D. H. Enhanced IL-18 expression in common skin tumors. Immunol. Lett., 79: 215-219, 2001.
29. Nakamura, S., Otani, T., Okura, R., Ijiri, Y., Motoda, R., Kurimoto, M., and Orita, K. Expression and responsiveness of human interleukin-18 receptor (IL-18R) on hematopoietic cell lines. Leukemia (Baltimore), 14: 1052-1059, 2000.
30. Pistoia, V. Production of cytokines by human B cells in health and disease. Immunol. Today, 18: 343-350, 1997.
31. Harris, N. L., Jaffe, E. S., Diebold, J., Flandrin, G., Muller-Hermelink, H. K., Vardiman, J., Lister, T. A., and Bloomfield, C. D. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November, 1997. Hematol. J., 1: 53-66, 2000.
32. Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J. K., Cleary, M. L., Delsol, G., De Wolf-Peeters, C., Falini, B., and Gatter, K. C. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84: 1361-1392, 1994.
33. Damle, R. N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S. L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S. M., Schulman, P., Vinciguerra, V. P., Rai, K. R., Ferrarini, M., and Chiorazzi, N. IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94: 1840-1847, 1999.
34. Hamblin, T. J., Orchard, J. A., Ibbotson, R. E., Davis, Z., Thomas, P. W., Stevenson, F. K., and Oscier, D. G. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood, 99: 1023-1029, 2002.
35. Crespo, M., Bosch, F., Villamor, N., Bellosillo, B., Colomer, D., Rozman, M., Marce, S., Lopez-Guillermo, A., Campo, E., and Montserrat, E. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N. Engl. J. Med., 348: 1764-1775, 2003.
36. Rosenwald, A., Alizadeh, A. A., Widhopf, G., Simon, R., Davis, R. E., Yu, X., Yang, L., Pickeral, O. K., Rassenti, L. Z., Powell, J., Botstein, D., Byrd, J. C., Grever, M. R., Cheson, B. D., Chiorazzi, N., Wilson, W. H., Kipps, T. J., Brown, P. O., and Staudt, L. M. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J. Exp. Med., 194: 1639-1647, 2001.
37. Klein, U., Tu, Y., Stolovitzky, G. A., Mattioli, M., Cattoretti, G., Husson, H., Freedman, A., Inghirami, G., Cro, L., Baldini, L., Neri, A., Califano, A., and Dalla-Favera, R. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J. Exp. Med., 194: 1625-1638, 2001.
38. Corcione, A., Ottonello, L., Tortolina, G., Facchetti, P., Airoldi, I., Guglielmino, R., Dadati, P., Truini, M., Sozzani, S., Dallegri, F., and Pistoia, V. Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells. J. Natl. Cancer Inst. (Bethesda), 92: 628-635, 2000.
39. Lagresle, C., Bella, C., and Defrance, T. Phenotypic and functional heterogeneity of the IgD- B cell compartment: identification of two major tonsillar B cell subsets. Int. Immunol., 5: 1259-1268, 1993.
40. Liu, Y. J., Barthelemy, C., de Bouteiller, O., Arpin, C., Durand, I., and Banchereau, J. Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. Immunity, 2: 239-248, 1995.
41. Airoldi, I., Guglielmino, R., Ghiotto, F., Corcione, A., Facchetti, P., Truini, M., and Pistoia, V. Cytokine gene expression in neoplastic B cells from human mantle cell, follicular, and marginal zone lymphomas and in their postulated normal counterparts. Cancer Res., 61: 1285-1290, 2001.
42. Dick, F. R., and Maca, R. D. The lymph node in chronic lymphocytic leukemia. Cancer (Phila.), 41: 283-292, 1978.
43. Airoldi, I., Gri, G., Marshall, J. D., Corcione, A., Facchetti, P., Guglielmino, R., Trinchieri, G., and Pistoia, V. Expression and function of IL-12 and IL-18 receptors on human tonsillar B cells. J. Immunol., 165: 6880-6888, 2000.
44. Yoshimoto, T., Okamura, H., Tagawa, Y. I., Iwakura, Y., and Nakanishi, K. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-γ production from activated B cells. Proc. Natl. Acad. Sci. USA, 94: 3948-3953, 1997.
45. Skok, J., Poudrier, J., and Gray, D. Dendritic cell-derived IL-12 promotes B cell induction of Th2 differentiation: a feedback regulation of Th1 development. J. Immunol., 163: 4284-4291, 1999.
46. Schultze, J. L., Michalak, S., Lowne, J., Wong, A., Gilleece, M. H., Gribben, J. G., and Nadler, L. M. Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon γ, and IL-10: role of B cells in the maintenance of T cell responses. J. Exp. Med., 189: 1-12, 1999.
47. Manetti, R., Gerosa, F., Giudizi, M. G., Biagiotti, R., Parronchi, P., Piccinni, M. P., Sampognaro, S., Maggi, E., Romagnani, S., Trinchieri, G., et al. Interleukin 12 induces stable priming for interferon γ (IFN-γ) production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 cell clones. J. Exp. Med., 179: 1273-1283, 1994.
48. Magram, J., Connaughton, S. E., Warrier, R. R., Carvajal, D. M., Wu, C. Y., Ferrante, J., Stewart, C., Sarmiento, U., Faherty, D. A., and Gately, M. K. IL-12-deficient mice are defective in IFN γ production and type 1 cytokine responses. Immunity, 4: 471-481, 1996.
49. Macatonia, S. E., Hosken, N. A., Litton, M., Vieira, P., Hsieh, C. S., Culpepper, J. A., Wysocka, M., Trinchieri, G., Murphy, K. M., and O'Garra, A. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J. Immunol., 154: 5071-5079, 1995.